Journal of Microbiology and Infection

ABSTRACT

Antibiotic resistance has become an urgent global health concern. The misuse of antibiotics in healthcare, agriculture, and veterinary practices has accelerated the development of resistant strains of bacteria. This escalating problem has rendered many antibiotics ineffective, leaving patients vulnerable to once-treatable infections. The World Health Organization (WHO) has warned that we are moving toward a "post-antibiotic era" where common infections and minor injuries could once again become life-threatening [1]. The development of new antibiotics has stagnated, as the costs and challenges associated with their discovery and approval have deterred pharmaceutical companies from investing in research and development. It is evident that we need innovative strategies to combat this crisis, and nanoparticles have emerged as a compelling candidate.

KEYWORDS